MCK Q1 2024 Earnings — McKesson Corporation Revenue & Financial Results | Market Cap Arena

MCKMcKesson Corporation

$115B

Q1 2024 Earnings

Healthcare Medical - Distribution

Income Statement

Revenue

$74.5B+10.9% YoY

Gross Profit

$2.8B3.8% margin

Operating Income

$1.0B1.4% margin

Net Income

$958M1.3% margin

EPS (Diluted)

$7.01

QoQ Revenue Growth

+8.1%

Cash Flow

Operating Cash Flow

-$1.1B

Free Cash Flow

-$1.2B

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$64.1B

Total Liabilities

$65.3B

Stockholders' Equity

-$1.6B

Cash & Equivalents

$2.6B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$74.5B	$67.2B	+10.9%
Gross Profit	$2.8B	$2.9B	-4.3%
Operating Income	$1.0B	$1.1B	-2.8%
Net Income	$958M	$768M	+24.7%

Revenue Segments

U.S. Pharmaceutical Segment

$67.2B90%

International Segment

$3.5B5%

Medical-Surgical Solutions Segment

$2.6B4%

Prescription Technology Solutions

$1.2B2%